Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Butt

Showing results (631-640 of 661) with videos related to

Pageof 67
Sort By:
The New England Journal of Medicine|June 15, 2022
Effects of Previous Infection and Vaccination on Symptomatic Omicron InfectionsHeba N Altarawneh, Hiam Chemaitelly, Houssein H Ayoub, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 17, 2021
Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta VariantLaith J Abu-Raddad, Hiam Chemaitelly, Houssein H Ayoub, et al.
The New England Journal of Medicine|March 9, 2022
Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in QatarLaith J Abu-Raddad, Hiam Chemaitelly, Houssein H Ayoub, et al.
JAMA Cardiology|April 7, 2017
Association Between HIV Infection and the Risk of Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy Era: Results From the Veterans Aging Cohort StudyMatthew S Freiberg, Chung-Chou H Chang, Melissa Skanderson, et al.
The New England Journal of Medicine|November 2, 2022
Covid-19 Vaccine Protection among Children and Adolescents in QatarHiam Chemaitelly, Sawsan AlMukdad, Houssein H Ayoub, et al.
Journal of Travel Medicine|May 31, 2022
Effects of BA.1/BA.2 subvariant, vaccination and prior infection on infectiousness of SARS-CoV-2 omicron infectionsSuelen H Qassim, Hiam Chemaitelly, Houssein H Ayoub, et al.
American Journal of Epidemiology|December 7, 2023
Estimating protection afforded by prior infection in preventing reinfection: applying the test-negative study designHoussein H Ayoub, Milan Tomy, Hiam Chemaitelly, et al.
Nature Medicine|November 3, 2021
BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in QatarPatrick Tang, Mohammad R Hasan, Hiam Chemaitelly, et al.
The Lancet. Infectious Diseases|March 13, 2023
Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort studyHiam Chemaitelly, Houssein H Ayoub, Patrick Tang, et al.
The Lancet. Microbe|November 14, 2022
Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort studyHiam Chemaitelly, Houssein H Ayoub, Sawsan AlMukdad, et al.
Pageof 67

Showing results (631-640 of 661) with videos related to

Sort By:
Pageof 67
The New England Journal of Medicine|June 15, 2022
Effects of Previous Infection and Vaccination on Symptomatic Omicron InfectionsHeba N Altarawneh, Hiam Chemaitelly, Houssein H Ayoub, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 17, 2021
Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta VariantLaith J Abu-Raddad, Hiam Chemaitelly, Houssein H Ayoub, et al.
The New England Journal of Medicine|March 9, 2022
Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in QatarLaith J Abu-Raddad, Hiam Chemaitelly, Houssein H Ayoub, et al.
JAMA Cardiology|April 7, 2017
Association Between HIV Infection and the Risk of Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy Era: Results From the Veterans Aging Cohort StudyMatthew S Freiberg, Chung-Chou H Chang, Melissa Skanderson, et al.
The New England Journal of Medicine|November 2, 2022
Covid-19 Vaccine Protection among Children and Adolescents in QatarHiam Chemaitelly, Sawsan AlMukdad, Houssein H Ayoub, et al.
Journal of Travel Medicine|May 31, 2022
Effects of BA.1/BA.2 subvariant, vaccination and prior infection on infectiousness of SARS-CoV-2 omicron infectionsSuelen H Qassim, Hiam Chemaitelly, Houssein H Ayoub, et al.
American Journal of Epidemiology|December 7, 2023
Estimating protection afforded by prior infection in preventing reinfection: applying the test-negative study designHoussein H Ayoub, Milan Tomy, Hiam Chemaitelly, et al.
Nature Medicine|November 3, 2021
BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in QatarPatrick Tang, Mohammad R Hasan, Hiam Chemaitelly, et al.
The Lancet. Infectious Diseases|March 13, 2023
Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort studyHiam Chemaitelly, Houssein H Ayoub, Patrick Tang, et al.
The Lancet. Microbe|November 14, 2022
Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort studyHiam Chemaitelly, Houssein H Ayoub, Sawsan AlMukdad, et al.
Pageof 67